Finance

Beta
Lists
CIPLA:NSE
Cipla Ltd
1 382,20 INR
+0,38%
(+5,20) 1D
11-июн., 15:17:53 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for CIPLA...
Open
1 376,10 INR
High
1 391,00 INR
Low
1 373,90 INR
Mkt. cap
1,12 трлн
Avg. vol.
1,87 млн
Volume
581,47 миң
Dividend
0,94%
Quarterly dividend
3,25 INR
Ex-dividend date
2026-ж., 5-июн.
P/E ratio
28,80
52-wk high
1 673,00 INR
52-wk low
1 165,70 INR
EPS
48,00 INR
Shares outstanding
805,67 млн
No. of employees
31 миң
Open
1 376,10 INR
High
1 391,00 INR
Low
1 373,90 INR
Mkt. cap
1,12 трлн
Avg. vol.
1,87 млн
Volume
581,47 миң
Dividend
0,94%
Quarterly dividend
3,25 INR
Ex-dividend date
2026-ж., 5-июн.
P/E ratio
28,80
52-wk high
1 673,00 INR
52-wk low
1 165,70 INR
EPS
48,00 INR
Shares outstanding
805,67 млн
No. of employees
31 миң
Analyst outlook
Analyst Ratings
Based on 3 analysts giving stock ratings to CIPLA in the past 3 months
Hold
Buy
1
Hold
1
Sell
1
12 month forecast
Based on 3 Wall Street analysts offering 12 month price targets for CIPLA in the last 3 months.
Highest
Current 1 382,20 INR
1 550,00 INR (+12,14%)
Average
1 403,33 INR (+1,53%)
Lowest
1 120,00 INR (-18,97%)
News stories
From sources across the web
Profile
Cipla Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, paediatric and various other medical conditions. Cipla has 47 manufacturing locations across the world and sells its products in 86 countries. It is the third-largest drug producer in India. Wikipedia
About Cipla Ltd
CEOUmang Vohra
Employees31,4 миң
Founded1935
HeadquartersМамбай, Махараштра, Индия
SectorPharmaceutical industry
Websitecipla.com
Last report
2026-ж., 13-май
Fiscal period
Q4 2026
EPS / Est. (INR)
6,86 INR / 9,67 INR
-29,07%miss
Revenue / Est. (INR)
65,80 млд / 67,14 млд
-1,99%miss
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
2025-ж. июн.
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
Revenue
68,37 млд
74,47 млд
69,63 млд
65,80 млд
Cost of goods sold
21,71 млд
24,98 млд
26,32 млд
25,10 млд
Cost of revenue
21,71 млд
24,98 млд
26,32 млд
25,10 млд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
13,12 млд
13,15 млд
13,25 млд
28,23 млд
Operating expense
31,41 млд
33,52 млд
33,54 млд
33,30 млд
Total operating expenses
53,12 млд
58,50 млд
59,86 млд
58,39 млд
Operating income
15,25 млд
15,98 млд
9,77 млд
7,41 млд
Other non operating income
2,59 млд
2,69 млд
2,06 млд
-5,35 млд
EBT including unusual items
17,69 млд
18,54 млд
8,93 млд
6,99 млд
EBT excluding unusual items
17,69 млд
18,54 млд
11,69 млд
4,51 млд
Income tax expense
4,78 млд
5,00 млд
2,19 млд
1,57 млд
Effective tax rate
27,01%
27,00%
24,48%
22,44%
Other operating expenses
15,76 млд
17,40 млд
17,51 млд
2,51 млд
Net income
12,98 млд
13,51 млд
6,76 млд
5,55 млд
Net profit margin
18,98%
18,14%
9,71%
8,43%
Earnings per share
16,06
16,72
10,94
6,86
Interest and investment income
-
-
-
2,07 млд
Interest expense
-140,50 млн
-131,80 млн
-140,30 млн
-69,70 млн
Net interest expenses
-140,50 млн
-131,80 млн
-140,30 млн
2,00 млд
Depreciation and amortization charges
2,53 млд
2,97 млд
2,78 млд
2,56 млд
EBITDA
17,49 млд
18,73 млд
12,00 млд
9,82 млд
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer